4-46312576-T-C
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000807.4(GABRA2):c.396A>G(p.Lys132Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 1,595,942 control chromosomes in the GnomAD database, including 145,514 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000807.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 78Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000807.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GABRA2 | NM_000807.4 | MANE Select | c.396A>G | p.Lys132Lys | synonymous | Exon 5 of 10 | NP_000798.2 | ||
| GABRA2 | NM_001330690.2 | c.396A>G | p.Lys132Lys | synonymous | Exon 5 of 11 | NP_001317619.1 | |||
| GABRA2 | NM_001377144.1 | c.396A>G | p.Lys132Lys | synonymous | Exon 5 of 11 | NP_001364073.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GABRA2 | ENST00000381620.9 | TSL:1 MANE Select | c.396A>G | p.Lys132Lys | synonymous | Exon 5 of 10 | ENSP00000371033.4 | ||
| GABRA2 | ENST00000515082.5 | TSL:1 | c.396A>G | p.Lys132Lys | synonymous | Exon 5 of 9 | ENSP00000423840.1 | ||
| GABRA2 | ENST00000507069.5 | TSL:3 | c.396A>G | p.Lys132Lys | synonymous | Exon 4 of 10 | ENSP00000427603.1 |
Frequencies
GnomAD3 genomes AF: 0.378 AC: 57479AN: 151908Hom.: 11565 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.404 AC: 95718AN: 237012 AF XY: 0.397 show subpopulations
GnomAD4 exome AF: 0.425 AC: 613714AN: 1443916Hom.: 133934 Cov.: 31 AF XY: 0.419 AC XY: 300932AN XY: 718114 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.378 AC: 57511AN: 152026Hom.: 11580 Cov.: 32 AF XY: 0.379 AC XY: 28136AN XY: 74302 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
GABRA2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at